Ectopic pregnancy prevalence is approximately 1-2% of all pregnancies, majority of which located in the fallopian tube. Among the risk factors for ectopic pregnancy is tubal factor - meaning a mechanical problem within the fallopian tube resulting in the pregnancy remaining in the fallopian tube. The treatment o tubal pregnancy can be expectant, medical via metotrexate or surgicl via laparoscopic salpingectomy of the involved fallopian tube. The purpose of this study is to assess the feasibility of chromotubation during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy hence assessing the function of the remaining fallopian tube and trying to predict future fertility for the patient.
None
Patients with a history of unilateral salpingectomy
Patients with suspected heterotopic pregnancy
Patients with suspected allergic reaction to blue dye injection
Single group
performing chromotubation during the laparoscopy in order to assess the tubal patency of the remaining fallopian tube
Procedure/SurgeryPerforming chromotubation )injection of blue dye to the fallopian tube via cevical catheter) during the laparoscopy in order to assess the tubal patency of the remaining fallopian tube
Precentage of successful chromotubation (passing of blue dye through the fallopian tube) during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy.
How many cases would demonstrate patent fallopian tube via blue dye injected verses how many occluded ones.
Percentage of adverse reaction to chromotubation during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy.
How many allergic reactions
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
